Aurobindo Pharma arm Eugia Pharmas Telangana unit receives warning letter from USFDA

Updated On: 14 August, 2026 02:32 PM IST | New Delhi | PTI

In May this year the company had stated that the US Food and Drug Administration inspected Unit-I, a formulation manufacturing facility of Eugia Pharma Specialities Ltd located at Telangana from February 16 to February 27, 2026

Listen to this article :

Aurobindo Pharma. Picture sourced from X.

Aurobindo Pharma on Friday said the US health regulator has issued a warning letter to a formulation manufacturing facility of its arm, Eugia Pharma Specialities Ltd, in Telangana.

In May this year the company had stated that the US Food and Drug Administration (USFDA) inspected Unit-I, a formulation manufacturing facility of Eugia Pharma Specialities Ltd located at Telangana from February 16 to February 27, 2026.